StonvexLoading…
StonvexStonvexStonvexCore line items from SNBR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.41B | $1.68B | $1.89B | $2.11B |
Operating Income | $-46.59M | $22.87M | $22.94M | $67.88M |
Net Income | $-131.96M | $-20.33M | $-15.29M | $36.61M |
EPS (Diluted) | $-5.77 | $-0.90 | $-0.68 | $1.60 |
Total Assets | $680.06M | $860.81M | $950.88M | $953.94M |
Total Liabilities | $1.26B | $1.31B | $1.39B | $1.39B |
Cash & Equivalents | $1.69M | $1.95M | $2.54M | $1.79M |
Free Cash Flow OCF − CapEx | $-17.69M | $3.64M | $-66.08M | $-33.32M |
Shares Outstanding | 22.86M | 22.39M | 22.23M | 22.01M |